Ranked #1 in 8 out of the 10 evaluated specialties by U.S. News
MyPatients provides referring primary care providers with secure access to their patients’ information.
Boston Children's has launched the world's 1st program dedicated to offering hand transplants to children who qualify.
Innovation insider is a semi-monthly e-newsletter analyzes innovations at Boston Children’s, other academic medical centers and from industry.
Read the latest blog by a Boston Children's doctor, clinician or staff member.
Support the hospital with a donation that helps kids get the care they need.
Boston Children's Hospital's Division of Nephrology's Research Program is involved in both basic and clinical research in transplantation biology, renal development, and nephrotic syndrome, particularly focal glomerulosclerosis and autosomal recessive polycystic disease of the kidney.
The Division of Nephrology is dedicated to developing lasting treatments for the most serious kidney diseases affecting children. Children's researchers in nephrology are also investigating the vascular component of the immune response with an eye toward new immunosuppression protocols. The Division has developed the largest and most active kidney transplant clinical trials group in the country in order to transfer such discoveries from the bench to the bedside.
Recognizing that developmental anomalies are responsible for over 50% of the causes of kidney failure in children, the division has assembled a very large developmental and regenerative biology team. And, in order to take advantage of the remarkable breakthroughs of modern genomics, Nephrology is developing a pharmacogenomics group.
Featured researchers in the Division of Nephrology hold faculty appointments at Harvard Medical School.
Please visit the Nephrology research page to find out more about our current work, researchers, laboratories, and more.
The future of pediatrics will be forged by thinking differently, breaking paradigms and joining together in a shared vision of tackling the toughest challenges before us.”